CLOs on the Move

Medgenics

www.medgenics.com

 
Medgenics is a clinical-stage biopharmaceutical company developing an innovative and proprietary platform technology - a biological "Biopump" - which allows patients to produce, within their bodies and on a long-term basis, their own natural human protein therapy for the treatment of a range of chronic diseases, such as anemia and hepatitis C.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.medgenics.com
  • 435 Devon Park Drive Bldg 700
    Wayne, PA USA 19087
  • Phone: 610.254.4201

Executives

Name Title Contact Details
Scott Applebaum
Chief Legal Officer Profile

Similar Companies

Pleio

Pleio is the leader in patient engagement and medication adherence. We build impactful relationships with patients on therapy using artfully-scripted, live, non-clinical conversations and digital outreach. Our multi-channel approach to engagement increases patient adherence, instills key messages, and delivers voice of patient insights. Pleio’s proven platform drives revenue, improves quality and reduces medical costs.

Unimed Usa

Unimed Usa is a San Rafael, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National HealthCare Services

National HealthCare Services is a Long Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mount Sinai New York University Health

Mount Sinai New York University Health is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in New York, NY. To find more information about Mount Sinai New York University Health, please visit www.msnyuhealth.org

Glytec System

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.